Arthur J. Gallagher & Co. ranks among the largest insurance brokerage and risk management firms globally, drawing revenue from commissions, fees, and claims-administration services. Its quarterly updates often reflect broader trends in commercial insurance pricing, client retention, and demand for risk services. The Q3 2026 report carried extra significance after the major AssuredPartners acquisition, which altered the revenue base and cost structure. I also checked this using Tickeron’s AI Screener to compare the stock against industry peers. Investors focused on whether AJG could extend its streak of double-digit adjusted EBITDAC growth despite softer pricing in some property and casualty lines and ongoing cost pressures from inflation.
For the third quarter of 2026, AJG reported total revenue of approximately $3.98 billion, an increase of roughly 18% from $3.365 billion in the same period last year. The figure landed slightly below the consensus estimate of about $4.00 billion, a top-line miss of roughly 0.6%. Combined Brokerage and Risk Management segment revenue grew 18%, including 5% organic growth, supported by strong client retention and new business.
On the bottom line, adjusted EPS of $3.00 edged past the consensus estimate of $2.99 and rose from $2.31 a year earlier. GAAP net earnings climbed to $406 million, or $1.55 per share, compared with $273 million, or $1.04 per share, in the prior-year period. Adjusted EBITDAC grew 25% to approximately $1.25 billion, extending the company’s streak of double-digit growth to 26 consecutive quarters, though it was marginally below the roughly $1.26 billion analysts had modeled. Management pointed to margin expansion and acquisition contributions as key drivers, while noting that lower interest-income revenue from prior-year AssuredPartners financing proceeds partially offset underlying performance. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to review recent trading patterns around the release.
The market’s initial response to the report was measured. Shares traded near $268 and were little changed to slightly lower in after-hours action, as the modest revenue shortfall and a slightly light adjusted EBITDAC print were balanced against an in-line-to-better adjusted EPS and continued margin expansion. The subdued reaction reflected a quarter with few dramatic surprises: solid organic growth and acquisition contributions were already well anticipated, and the small top-line miss did not alter the broader narrative of resilient demand. Sentiment heading into the print had leaned cautious, with more downward than upward EPS revisions over the prior 90 days, so the steady results provided reassurance without triggering a sharp repricing.
Looking ahead, investors will be watching whether organic growth can remain in the mid-single digits as insurance pricing conditions evolve across property and casualty lines. Renewal-rate trends, client retention, and new business generation will be key signals of the underlying demand environment.
The integration of AssuredPartners and the contribution from newly completed acquisitions remain central to the outlook. Management’s two-pronged strategy pairs organic expansion with deal activity, so the pace of future tuck-in acquisitions and the realization of cost synergies will influence both revenue growth and margin trajectory.
Cost trends also warrant attention. Compensation expense ratios, integration-related charges, and the lower interest-income contribution from prior financing proceeds could continue to shape profitability. A continued run of margin expansion alongside disciplined expense management would support the company’s long streak of adjusted EBITDAC growth, while any softening in organic growth or client activity could prompt investors to reassess valuation. From what I see, these factors will determine how sustainable the current momentum remains.
I often rely on Tickeron’s AI Screener to filter stocks by fundamentals, technical patterns, and industry trends. It provides a structured way to compare names like AJG against peers and surface relevant signals without manual effort. This approach has become a regular part of how I review quarterly results and sector positioning.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day moving average for AJG crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on AJG as a result. In 51 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
The Moving Average Convergence Divergence (MACD) for AJG just turned positive on October 08, 2026. Looking at past instances where AJG's MACD turned positive, the stock continued to rise in 27 of 45 cases over the following month. The odds of a continued upward trend are 60%.
AJG moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +6.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where AJG advanced for three days, in 208 of 365 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AJG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
AJG broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AJG entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 14 (best 1 - 100 worst), indicating outstanding price growth. AJG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 50 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.984) is normal, around the industry mean (2.659). P/E Ratio (45.257) is within average values for comparable stocks, (18.304). Projected Growth (PEG Ratio) (0.679) is also within normal values, averaging (8.322). Dividend Yield (0.010) settles around the average of (0.045) among similar stocks. P/S Ratio (4.021) is also within normal values, averaging (2.968).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of insurance brokerage and third-party claims settlement and administration services.
Industry InsuranceBrokersServices